References
- SO Bachurin. (2003). Medicinal chemistry approaches for the treatment and prevention of Alzheimer's disease. Med Res Rev 23 (1):48–88.
- P Tariot, and H Federoff. (2003). Current treatment for Alzheimer disease and future prospects. Alzheimer Dis Assoc Disord 17:105–113.
- E Giacobini. (2004). Cholinesterase inhibitors: New roles and therapeutic alternatives. Pharmacol Res 50 (4):433–440.
- J Evans, G Wilcock, and J Birks. (2004). Evidence-based pharmacotherapy of Alzheimer's disease. Int J Neuropsychopharmacol 7 (3):351–369.
- J Hardy, and DJ Selkoe. (2002). The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics. Science 297 (5580):353–356.
- GV De Ferrari, MA Canales, I Shin, LM Weiner, I Silman, and NC Inestrosa. (2001). A structural motif of acetylcholinesterase that promotes amyloid beta-peptide fibril formation. Biochemistry 40 (35):10447–10457.
- D Alonso, I Dorronsoro, L Rubio, P Munoz, E Garcia-Palomero, M Del Monte, A Bidon-Chanal, M Orozco, FJ Luque, A Castro, M Medina, and A Martinez. (2005). Donepezil-tacrine hybrid related derivatives as new dual binding site inhibitors of AChE. Bioorg Med Chem 13 (24):6588–6597.
- L Piazzi, F Belluti, A Bisi, S Gobbi, S Rizzo, M Bartolini, V Andrisano, M Recanatini, and A Rampa. (2007). Cholinesterase inhibitors: SAR and enzyme inhibitory activity of 3-[omega- (benzylmethylamino)alkoxy] xanthen-9-ones. Bioorg Med Chem 15 (1):575–585.
- CN Wang, CW Chi, YL Lin, CF Chen, and YJ Shiao. (2001). The neuroprotective effects of phytoestrogens on amyloid beta protein-induced toxicity are mediated by abrogating the activation of caspase cascade in rat cortical neurons. J Biol Chem 276:5287–5295.
- H Kim, BS Park, KG Lee, CY Choi, SS Jang, YH Kim, and SE Lee. (2005). Effects of naturally occurring compounds on fibril formation and oxidative stress of β-amyloid. J Agric Food Chem 53 (22):8537–8541.
- J Zhu, R Choi, G Chu, A Cheung, Q Gao, J Li, ZY Jiang, T Dong, and K Tsim. (2007). Flavonoids possess neuroprotective effects on cultured pheochromocytoma PC12 cells: A comparison of different flavonoids in activating estrogenic effect and in preventing β-amyloid-induced cell death. J Agric Food Chem 55 (6):2438–2445.
- G Kryger, I Silman, and JL Sussman. (1998). Three-dimensional structure of a complex of E2020 with acetylcholinesterase from Torpedo Californica. J Physiol (Paris) 92:191–194.
- O Mitsunobu. (1981). The use of diethyl azodicarboxylate and triphenylphosphine in synthesis and transformation of natural products. Synthesis 1:1–28.
- Shaw J, Lee AR, Huang WH. Methods of synthesizing flavonoids and chalcones, US 2004242907.
- L Xiao, WF Tan, and YL Li. (1998). First total synthesis of ( ± )-kenusanone B. Synth Commun 28 (15):2861–2869.
- S Mavel, B Dikic, and S Palakas. (2006). Synthesis and biological evaluation of a series of flavone derivatives as potential radioligands for imaging the multidrug resistance-associated protein 1 (ABCC1/MRP1). Bioorg Med Chem 14 (5):1599–1607.
- T Masao, W Hironari, and K Yasuhiko. (2004). Regioselective synthesis of 6-alkyl- and 6-prenylpolyhydroxyisoflavones and 6-alkylcoumaronochromone derivatives. Chem Pharm Bull 52 (11):1285–1289.
- K Yasuhiko, M Masashi, and T Takanori. (2002). Synthesis of isoflavones from 2′-hydroxy- chalcones using poly[4-(diacetoxy)iodo]styrene or related hypervalent iodine reagent. Synthesis 17:2490–2496.
- MS Cousins, DL Carriero, and JD Salamone. (1997). Tremulous jaw movements induced by the acetylcholinesterase inhibitor tacrine: Effects of antiparkinsonian drugs. Eur J Pharmacol 322:137–145.
- GL Ellman, KD Courtney, V AndresJr., and RM Featherstone. (1961). A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7:88–95.
- DH Cheng, and XC Tang. (1998). Comparative studies of huperzine A, E2020, and tacrine on behavior and cholinesterase activities. Pharmacol Biochem Behav 60 (2):377–386.
- SYBYL 6.9 molecular modeling program., Tripos Associates.